A preclinical study unexpectedly identified the gene Foxo1 as a potential treatment target for hereditary lymphedema. Valve loss or dysfunction that disrupts the flow of lymph fluid is strongly associated with lymphedema in patients. But no one has discovered whether new valves can be grown or if defective ones can be fixed. The new study, using a model of human primary lymphedema, shows that both are possible.
source https://www.sciencedaily.com/releases/2021/08/210810110953.htm
Wednesday, 11 August 2021
Related Posts
Managing attention deficit disorder by training the brainScientists explored a technique called 'neurofeedback,' which enables … Read More
The evolution of axial patterningBody axes are molecular coordinate systems along which regulatory gene… Read More
Cell biology: Masters of synapse modulationResearchers have shown how RNA-binding proteins modulate synaptic resp… Read More
Dinosaurs were in decline before the endThe death of the dinosaurs 66 million years ago was caused by the impa… Read More
Diversity of tiny bobtail squid driven by ancient biogeographic events, finds new studyResearchers took a close look at bobtail and bottletail squids to esta… Read More
Parasites manipulate praying mantis's polarized-light perception, causing it to jump into waterResearchers have revealed that praying mantis (mantids) infected with … Read More
0 comments: